Phase I study of low-dose suramin as a chemosensitizer in patients with advanced non-small cell lung cancer.
Phase I study of low-dose suramin as a chemosensitizer in patients with advanced non-small cell lung cancer. Clin Cancer Res. 2003 Aug 15; 9(9):3303-11.